Stocktoria
4D Molecular Therapeutics, Inc. FDMT
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-12-11
4D Molecular Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 4,896,897 | $102.8M | 8.45% |
| CITADEL ADVISORS LLC | 901,197 | $12.0M | 1.56% |
| RENAISSANCE TECHNOLOGIES LLC | 614,573 | $8.2M | 1.06% |
| TWO SIGMA INVESTMENTS, LP | 69,481 | $924,097 | 0.12% |
| AQR CAPITAL MANAGEMENT LLC | 50,281 | $668,737 | 0.09% |
| D. E. Shaw & Co., Inc. | 44,354 | $589,908 | 0.08% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.